Generated: October 22, 2017
DrugPatentWatch Database Preview
DOXYCYCLINE Drug Profile
What is the patent landscape for Doxycycline, and when can generic versions of Doxycycline launch?
is a drug marketed by Heritage Pharms Inc, Mylan Labs Ltd, Zydus Pharms Usa Inc, Mylan, Sandoz Inc, Lupin Ltd, Watson Labs, G And W Labs Inc, West-ward Pharms Int, Sun Pharm Inds Ltd, Chartwell Life Sci, Par Pharm, Alembic Pharms Ltd, Impax Labs Inc, Sun Pharm Inds, Mylan Pharms Inc, Lannett, Mayne Pharma Inc, Hikma Intl Pharms, Mutual Pharm, Halsey, Actavis Labs Fl Inc, Pvt Form, Actavis Elizabeth, Vintage Pharms, Novel Labs Inc, Heather, Interpharm, Ivax Sub Teva Pharms, Superpharm, Caribe Holdings, Amneal Pharms Co, Ranbaxy, Medicis, Epic Pharma Llc, Pliva, Larken Labs, Amneal Pharms, Warner Chilcott, and Prinston Inc. and is included in seventy-seven NDAs.
The generic ingredient in DOXYCYCLINE is doxycycline hyclate. There are twenty-seven drug master file entries for this compound. Ninety-three suppliers are listed for this compound. There are four tentative approvals for this compound. Additional details are available on the doxycycline hyclate profile page.
Summary for Tradename: DOXYCYCLINE
|CAPSULE;ORAL||061717-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
Mylan Pharms Inc
|TABLET, DELAYED RELEASE;ORAL||091052-001||Feb 8, 2012||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
West-ward Pharms Int
|INJECTABLE;INJECTION||062569-001||Mar 9, 1988||AP||RX||No||Yes||► Subscribe||► Subscribe||► Subscribe|
|CAPSULE;ORAL||065055-003||Jul 15, 2005||AB||RX||No||Yes||► Subscribe||► Subscribe||► Subscribe|
|TABLET, DELAYED RELEASE;ORAL||090431-001||Dec 28, 2010||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
Mayne Pharma Inc
|TABLET;ORAL||208765-002||Jun 14, 2017||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|TABLET, DELAYED RELEASE;ORAL||207494-001||Nov 15, 2016||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
Sun Pharm Inds
|TABLET;ORAL||065471-003||Apr 17, 2009||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
Ivax Sub Teva Pharms
|TABLET;ORAL||065163-001||May 13, 2005||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|TABLET;ORAL||065285-003||Jul 30, 2008||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.